Revance Therapeutics, Inc.

DB:RTI Stock Report

Market Cap: €368.7m

Revance Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:RTI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 Apr 24Sell€8,559Erica JordanIndividual2,392€3.58
18 Mar 24Sell€37,685Dwight MoxieIndividual8,125€4.64
18 Mar 24Sell€42,721Dustin SjutsIndividual9,211€4.64
18 Mar 24Sell€43,418Tobin SchilkeIndividual9,361€4.64
06 Mar 24Buy€192,083Mark FoleyIndividual30,000€6.40
20 Oct 23Buy€17,794,362Teoxane S.A.Company2,105,000€8.91
22 Aug 23Buy€25,921,279Teoxane S.A.Company1,392,000€23.85
15 May 23Sell€667,778Dustin SjutsIndividual21,015€31.78
15 May 23Sell€2,238,541Mark FoleyIndividual70,447€31.78
15 May 23Sell€680,043Tobin SchilkeIndividual21,401€31.78
15 May 23Sell€680,043Dwight MoxieIndividual21,401€31.78

Insider Trading Volume

Insider Buying: RTI insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of RTI?
Owner TypeNumber of SharesOwnership Percentage
State or Government1,359,0921.3%
Individual Insiders1,700,9541.63%
Hedge Funds5,237,2845.03%
Sovereign Wealth Funds5,825,8815.59%
Private Companies6,557,6236.29%
General Public18,041,38617.3%
Institutions65,493,39462.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.3%.


Top Shareholders

Top 25 shareholders own 68.22% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.5%
Capital Research and Management Company
11,939,076€42.2m-0.18%no data
7.15%
BlackRock, Inc.
7,453,371€26.4m10.3%no data
6.29%
Teoxane S.A.
6,550,800€23.2m47.4%no data
5.59%
GIC Private Limited
5,825,881€20.6m40.9%0.03%
5.03%
Palo Alto Investors LP
5,237,284€18.5m0.17%2.12%
4.86%
The Vanguard Group, Inc.
5,069,625€17.9m5.81%no data
4.52%
Franklin Resources, Inc.
4,705,640€16.6m17.7%0.01%
3.04%
Polar Capital Holdings Plc
3,169,239€11.2m-23.8%0.05%
2.56%
JP Morgan Asset Management
2,666,144€9.4m-40.1%no data
2.42%
State Street Global Advisors, Inc.
2,521,693€8.9m8.08%no data
1.85%
Geode Capital Management, LLC
1,924,421€6.8m8.1%no data
1.53%
Invesco Ltd.
1,595,091€5.6m-44.9%no data
1.4%
Rubric Capital Management LP
1,461,474€5.2m-8.66%0.17%
1.3%
Monetary Authority of Singapore
1,359,092€4.8m0%no data
1.1%
CIBC Asset Management Inc.
1,147,294€4.1m251%0.01%
1.06%
Mark Foley
1,105,848€3.9m7.82%no data
0.99%
Jennison Associates LLC
1,032,352€3.7m3.48%no data
0.98%
Baron Capital Group, Inc.
1,023,663€3.6m0.34%0.01%
0.93%
Walleye Capital LLC
970,586€3.4m205%0.03%
0.85%
Northern Trust Global Investments
887,536€3.1m5.87%no data
0.72%
Rice Hall James & Associates, LLC
746,139€2.6m-1.57%0.16%
0.68%
Morgan Stanley, Investment Banking and Brokerage Investments
708,314€2.5m95.9%no data
0.66%
Goldman Sachs Group, Investment Banking and Securities Investments
687,534€2.4m-33.9%no data
0.65%
Charles Schwab Investment Management, Inc.
677,364€2.4m0%no data
0.6%
EULAV Asset Management
630,000€2.2m5%0.07%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.